Mutations in genes in the mTOR pathway, such as KRAS, epidermal growth factor receptor (EGFR), LKB1, PTEN, PIK3CA, AKT1, EGFR, PIK3CA, and PTEN, have some relationship with the development of NSCLC (29). Here, MTOR is linked to non-small cell lung carcinoma.